Markets
MA Stock Indexes
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
Charles River Laboratories International, Inc. (NY: CRL)
44.99 USD  +0.08 (+0.18%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Charles River Laboratories International, Inc.
 
< Previous 1 2 3 4 5 6 Next >
Charles River Laboratories to Present at Baird’s Growth Stock Conference
May 06, 2013
from Business Wire News Releases
Charles River Laboratories Announces First-Quarter 2013 Results from Continuing Operations
May 01, 2013
from Business Wire News Releases
Charles River Laboratories Schedules First-Quarter 2013 Earnings Release and Conference Call
April 08, 2013
from Business Wire News Releases
Free Research Reports on CRL, HL, TSLA and VVUS Issued by the Paragon Report
April 05, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Drug Approvals, Increased R&D and Strong Product Portfolios Driving New Growth - Research Report on Medivation, MannKind, Questcor Pharmaceuticals, Charles River Laboratories and Peregrine Pharmaceuti
March 12, 2013
from PR Newswire
Charles River Laboratories to Present at March Investor Conferences
March 01, 2013
from Business Wire News Releases
Free Research Report on United Therapeutics Corp., Embraer S.A., Charles River Laboratories International, Inc., PolyOne Corp. and Telefonica Brasil, S.A.
February 15, 2013
from Marketwired News Releases
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2012 Results from Continuing Operations
February 13, 2013
from Business Wire News Releases
Charles River Laboratories Schedules Fourth-Quarter and Full-Year 2012 Earnings Release and Conference Call
January 22, 2013
from Business Wire News Releases
Charles River Laboratories Completes Acquisition of Majority Ownership of Vital River
January 07, 2013
from Business Wire News Releases
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
January 07, 2013
from Business Wire News Releases
Charles River Laboratories Provides 2013 Financial Guidance
December 12, 2012
from Business Wire News Releases
Charles River Laboratories Schedules 2013 Guidance Release and Conference Call
November 29, 2012
from Business Wire News Releases
Charles River Laboratories Announces Third-Quarter 2012 Results from Continuing Operations
October 30, 2012
from Business Wire News Releases
Charles River Laboratories to Expand Research Models Business in China
October 30, 2012
from Business Wire News Releases
Charles River Laboratories Enters Strategic Partnership with AstraZeneca
October 17, 2012
from Business Wire News Releases
Charles River Schedules Third-Quarter 2012 Earnings Release and Conference Call
October 01, 2012
from Business Wire News Releases
Charles River to Present at Morgan Stanley Healthcare Conference
September 10, 2012
from Business Wire News Releases
Charles River Opens New Biomedical Diagnostic Facility
September 06, 2012
from Business Wire News Releases
Charles River Acquires Accugenix
August 29, 2012
from Business Wire News Releases
Charles River Announces Second-Quarter 2012 Results from Continuing Operations
August 07, 2012
from Business Wire News Releases
Charles River Schedules Second-Quarter 2012 Earnings Release and Conference Call
June 29, 2012
from Business Wire News Releases
Charles River to Present at June Investor Conferences
June 04, 2012
from Business Wire News Releases
Charles River to Present at May Conferences
May 07, 2012
from Business Wire News Releases
Charles River Announces First-Quarter 2012 Results from Continuing Operations
May 02, 2012
from Business Wire News Releases
The Alzheimer's Drug Discovery Foundation and Charles River Announce Awards for the Cognitive Aging and Alzheimer's Disease Research Program
April 10, 2012
from PR Newswire
Charles River Schedules First-Quarter 2012 Earnings Release and Conference Call
April 04, 2012
from Business Wire News Releases
StemCells, Inc. Grants genOway Exclusive License to Gene Insertion Technology for Genetically Engineered Mice
March 20, 2012
genOway to be Exclusive Source Worldwide for This Cell Manipulation Technology in Genetically Modified Mice Read More
from GlobeNewswire News Releases
Charles River to Present at Upcoming Investor Conferences
February 23, 2012
from Business Wire News Releases
Charles River Announces Fourth-Quarter and Full-Year 2011 Results from Continuing Operations
February 13, 2012
from Business Wire News Releases
< Previous 1 2 3 4 5 6 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here